20
Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PREGABALIN (ALTERNATIVE PROCESS), with a corresponding US DMF Number 30790.
Remarkably, this DMF maintains an Active status since its submission on August 01, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 08, 2016, and payment made on August 18, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II